Apple India may cross Rs 30,000 crore revenue in FY2022
Medilytix Bureau: After clocking record sales last year, consumer technology giant Apple is set to break its own sales record in FY2022 in India. Buoyed on continued surge in demand…
Medilytix Bureau: After clocking record sales last year, consumer technology giant Apple is set to break its own sales record in FY2022 in India. Buoyed on continued surge in demand…
Medilytix Bureau: Mindtree share price slipped over 5% today despite the firm reporting a healthy set of earnings in Q3 of the current fiscal. The IT services company posted a…
Medilytix Bureau: The country’s largest private sector lender HDFC Bank on Saturday reported an 18.1 per cent rise in its standalone net profit at Rs 10,342.20 crore for the third…
Pratibha reports Bhavish Aggarwal, Ola CEO on Saturday said that Ola Electric is upgrading its Ola S1 electric scooter customers to the hardware of its Ola S1 Pro scooters. Aggarwal…
Medilytix Bureau: Business services platform IndiaFilings has raised Rs 32 crore ($4.3 million) in a pre-Series A round of investment from boutique investment banking firm CreedCap Asia Advisors, Singapore-headquartered venture…
Medilytix Bureau: Hygienic practices in preparing the prasad while following the COVID guidelines and strictures give BHOG certification to Iskcon temple of bhubaneswar. This certification is given by Food Safety…
Medilytix Bureau: Startups from various sectors including Agriculture, Health, Enterprise Systems, Space, Industry 4.0, Security, Fintech, Environment etc will be part of this interaction. More than 150 startups have been…
Medilytix Bureau: The Central government has approved the service period extension of Chief Secretary, Suresh Chandra Mahapatra for six months after his superannuation on February 28. The 1986 batch IAS…
Medilytix Desk: Axis Bank has tied up with MinkasuPay, a mobile payments company based in Silicon Valley, California, to offer a smooth net banking payment experience to its customers through…
Medilytix Bureau: Bharat Biotech has sought from the Drugs Controller General of India regular market approval for its COVID-19 vaccine Covaxin’, which is currently only authorised for emergency use in…